The table below shows Wave Life Sciences Ltd.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$59.55M
-$63.04M
-$33.43M
$85.52M
-$39.87M
-$44.38M
Capital expenditure
$438.00K
$165.00K
$417.00K
$489.00K
$208.00K
$108.00K
Investing cash flow
-$438.00K
-$165.00K
-$417.00K
-$489.00K
-$50.21M
-$108.00K
Dividends paid
-
-
-
WVE operating cash flow (10-K history)
Wave Life Sciences Ltd. reported operating cash flow of -$187.49M for fiscal year 2025. That is down 24.1% from -$151.03M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$31.93M (FY 2016) to -$187.49M. Figures come from the company's audited annual reports as filed with the SEC.
